Stocks and Investing
Stocks and Investing
Mon, February 28, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Colin Bristow Downgraded (ABBV) to Hold and Increased Target to $147 on, Feb 28th, 2022
Colin Bristow of UBS, Downgraded "AbbVie Inc." (ABBV) to Hold and Increased Target from $129 to $147 on, Feb 28th, 2022.
Colin has made no other calls on ABBV in the last 4 months.
There are 16 other peers that have a rating on ABBV. Out of the 16 peers that are also analyzing ABBV, 3 agree with Colin's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Geoff Meacham of "B of A Securities" Maintained at Hold with Increased Target to $138 on, Thursday, February 3rd, 2022
- Chris Shibutani of "Goldman Sachs" Maintained at Hold with Increased Target to $122 on, Thursday, February 3rd, 2022
- Carter Gould of "Barclays" Maintained at Hold with Increased Target to $150 on, Thursday, February 3rd, 2022
These are the ratings of the 13 analyists that currently disagree with Colin
- Gary Nachman of "BMO Capital" Maintained at Buy with Increased Target to $161 on, Wednesday, February 23rd, 2022
- Robyn Karnauskas of "Truist Securities" Maintained at Strong Buy with Increased Target to $160 on, Tuesday, February 15th, 2022
- Vamil Divan of "Mizuho" Maintained at Strong Buy with Increased Target to $166 on, Friday, February 4th, 2022
- Andrew Baum of "Citigroup" Maintained at Strong Buy with Increased Target to $155 on, Thursday, January 27th, 2022
- Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $142 on, Monday, January 24th, 2022
- Steve Scala of "TD Cowen" Maintained at Buy with Increased Target to $150 on, Tuesday, January 18th, 2022
- Christopher Raymond of "Piper Sandler" Reiterated at Buy and Held Target at $160 on, Tuesday, January 18th, 2022
- Charles Pitman of "Redburn Partners" Initiated at Strong Buy on, Thursday, January 13th, 2022
- Aaron Gal of "Bernstein" Maintained at Buy with Increased Target to $155 on, Monday, January 3rd, 2022
- Mohit Bansal of "Wells Fargo" Initiated at Buy and Held Target at $165 on, Thursday, December 9th, 2021
- Navin Jacob of "UBS" Maintained at Strong Buy with Increased Target to $129 on, Monday, November 29th, 2021
- Justin Smith of "Societe Generale" Upgraded from Hold to Strong Buy and Held Target at $172 on, Tuesday, November 23rd, 2021
- Geoffrey Porges of "SVB Leerink" Maintained at Buy with Decreased Target to $135 on, Monday, November 1st, 2021
Contributing Sources